GL1X · GenesisL1 explorer

MolNFT v1 · #165589 · protein

Discovery of lysine-targeted EIF4E inhibitors through covalent docking

6U06: “Discovery of lysine-targeted EIF4E inhibitors through covalent docking”. X-ray diffraction, 1 ligand (EI8). MolNFT v1 #165589 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6U06
Type
protein
Length
728 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
P63073
Ligands
EI8

Structure

x-ray diffraction · 3 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B—protein182—P63073
C—protein182—P63073
D—protein182—P63073

Ligands and binding sites

  • EI8 · 3-{[(4-cyanophenyl)methyl](1-oxo-1,2-dihydroisoquinolin-7-yl)sulfamoyl}benzene-1-sulfonyl fluoride · ligand · 4 copies · chains A, B, C, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 6U06 · Discovery of Lysine-Targeted eIF4E Inhibitors through Covalent Docking · the same entry in another collection · chain A against A, TM-score 1.00
  • P63073 · AlphaFold monomer V2.0 prediction for eukaryotic translation initiation factor 4E (P63073) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.